Citigroup analyst Fatima Boolani downgrades Varonis Systems (NASDAQ:VRNS) from Buy to Neutral and announces $21 price target.
Citigroup Downgrades Varonis Systems to Neutral, Announces $21 Price Target
Citigroup analyst Fatima Boolani downgrades Varonis Systems (NASDAQ:VRNS) from Buy to Neutral and announces $21 price target.
Related Posts
Agenus Sponsored Study Titled ‘A Phase 2 Study of Balstilimab Independently or in Combination With Zalifrelimab in Cervical Cancer’ Posted To ClinicalTrials.gov; Study Is Not Recruiting
https://clinicaltrials.gov/ct2/show/NCT05033132
Meta Could Be Forced To Blackout Facebook, Instagram From EU Pending This Agreement: Report
Facebook parent Meta Platforms, Inc (NASDAQ:META) again threatened to pull its popular Facebook and Instagram services from the European Union,…